These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8932455)
1. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Calvo P; Sanchez A; Martinez J; Lopez MI; Calonge M; Pastor JC; Alonso MJ Pharm Res; 1996 Feb; 13(2):311-5. PubMed ID: 8932455 [TBL] [Abstract][Full Text] [Related]
2. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. De Campos AM; Sánchez A; Alonso MJ Int J Pharm; 2001 Aug; 224(1-2):159-68. PubMed ID: 11472825 [TBL] [Abstract][Full Text] [Related]
3. Treatment of endotoxin-induced uveitis by topical application of cyclosporine a-loaded PolyGel™ in rabbit eyes. Alshamsan A; Abul Kalam M; Vakili MR; Binkhathlan Z; Raish M; Ali R; Alturki TA; Safaei Nikouei N; Lavasanifar A Int J Pharm; 2019 Oct; 569():118573. PubMed ID: 31356955 [TBL] [Abstract][Full Text] [Related]
4. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy. Molpeceres J; Chacón M; Guzmán M; Berges L; del Rosario Aberturas M Int J Pharm; 1999 Sep; 187(1):101-13. PubMed ID: 10502617 [TBL] [Abstract][Full Text] [Related]
5. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats]. Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479 [TBL] [Abstract][Full Text] [Related]
6. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Losa C; Marchal-Heussler L; Orallo F; Vila Jato JL; Alonso MJ Pharm Res; 1993 Jan; 10(1):80-7. PubMed ID: 8094245 [TBL] [Abstract][Full Text] [Related]
7. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution. Shen J; Deng Y; Jin X; Ping Q; Su Z; Li L Int J Pharm; 2010 Dec; 402(1-2):248-53. PubMed ID: 20934499 [TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study. Le Bourlais CA; Chevanne F; Turlin B; Acar L; Zia H; Sado PA; Needham TE; Leverge R J Microencapsul; 1997; 14(4):457-67. PubMed ID: 9229345 [TBL] [Abstract][Full Text] [Related]
9. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats. Yang ZQ; Xu J; Pan P; Zhang XN Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat. Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469 [TBL] [Abstract][Full Text] [Related]
11. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Park MJ; Balakrishnan P; Yang SG Int J Pharm; 2013 Jan; 441(1-2):757-64. PubMed ID: 23089581 [TBL] [Abstract][Full Text] [Related]
12. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. De Campos AM; Sánchez A; Gref R; Calvo P; Alonso MJ Eur J Pharm Sci; 2003 Sep; 20(1):73-81. PubMed ID: 13678795 [TBL] [Abstract][Full Text] [Related]
13. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Di Tommaso C; Valamanesh F; Miller F; Furrer P; Rodriguez-Aller M; Behar-Cohen F; Gurny R; Möller M Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2292-9. PubMed ID: 22427552 [TBL] [Abstract][Full Text] [Related]
14. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs. Agarwal P; Scherer D; Günther B; Rupenthal ID Int J Pharm; 2018 Mar; 538(1-2):119-129. PubMed ID: 29339249 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. Calvo P; Vila-Jato JL; Alonso MJ J Pharm Sci; 1996 May; 85(5):530-6. PubMed ID: 8742946 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Yenice I; Mocan MC; Palaska E; Bochot A; Bilensoy E; Vural I; Irkeç M; Hincal AA Exp Eye Res; 2008 Sep; 87(3):162-7. PubMed ID: 18675411 [TBL] [Abstract][Full Text] [Related]
17. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels. Wu Y; Yao J; Zhou J; Dahmani FZ Int J Nanomedicine; 2013; 8():3587-601. PubMed ID: 24092975 [TBL] [Abstract][Full Text] [Related]
18. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation. Alvarez-Trabado J; López-García A; Martín-Pastor M; Diebold Y; Sanchez A Int J Pharm; 2018 Jul; 546(1-2):20-30. PubMed ID: 29753904 [TBL] [Abstract][Full Text] [Related]
19. [The immunosuppressive effects of 0.025% cyclosporin eye drops in alpha cyclodextrin on rabbit corneal allografts]. Takano T; Kobayashi C; Alba RM; Kanai A Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):834-40. PubMed ID: 1502981 [TBL] [Abstract][Full Text] [Related]
20. Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. Molpeceres J; Aberturas MR; Guzman M J Microencapsul; 2000; 17(5):599-614. PubMed ID: 11038119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]